"Nootropic" is a marketing word, not a regulated category. The term comes from papers by Corneliu Giurgea in 1972 and 1973. Today it covers almost any supplement sold for focus, memory or mental energy.
The honest short answer: a handful of ingredients have modest, specific evidence in healthy adults. Caffeine raises alertness, though regular users may mostly be reversing withdrawal. Caffeine with L-theanine improved one attention measure in pooled trials. Creatine improved memory scores, mainly in older adults. Bacopa showed small effects on speed of attention after 12 weeks or more. Most other popular ingredients rest on thin, mixed or industry-funded evidence. Huperzine A's largest Western trial missed its primary endpoint.
The other half of the answer is on the label. A proven ingredient does nothing for you below the dose that was tested. Many products never tell you that dose.
In the US, the FDA does not have the authority to approve dietary supplements for safety and effectiveness. That framework comes from the Dietary Supplement Health and Education Act of 1994 (DSHEA). Companies, not the FDA, are responsible for making sure their products meet safety standards.
A product intended to treat, prevent or cure a disease is legally a drug, not a supplement. That line matters in this category. In 2019 the FDA sent warning letters to companies selling piracetam, the original "nootropic", treating those products as unapproved new drugs.
So a supplement labelled "nootropic" has passed no efficacy review. The evidence below is what you have to go on.
"Strength" is our reading of the human trials cited here. It is a summary, not a formal grade.
The FDA cites 400mg a day as an amount not generally associated with negative effects in healthy adults. In one trial, 50mg improved self-rated alertness at 60 minutes.
There is a catch. A review by James and Rogers argued that caffeine's apparent benefits in regular users are almost wholly withdrawal reversal. A later trial found no net alertness gain in regular users: abstaining lowered alertness and caffeine restored it. Not every researcher accepts that view, but it is a serious one.
In a 27-person crossover trial, 50mg caffeine plus 100mg L-theanine improved speed and accuracy of attention-switching versus placebo. A 2025 meta-analysis found a significant gain in attention-switching accuracy in the second hour (SMD 0.33). Choice reaction time and overall mood did not reach significance. We cover the full detail in our L-theanine and caffeine explainer.
A 2023 meta-analysis of eight trials found creatine improved memory versus placebo (SMD 0.29, 95% CI 0.04 to 0.53). The effect was large in adults aged 66–76 (SMD 0.88) and absent in people aged 11–31 (SMD 0.03). Proco does not sell creatine.
A meta-analysis of nine trials, all dosing for 12 weeks or more, found small improvements in two speed-of-attention measures. A 12-week trial using 300mg a day reported gains in learning and memory consolidation. A single 300mg dose changed nothing measurable after two hours. More in our bacopa evidence review.
In a 100-person trial of citicoline 500mg a day, the primary outcome did not differ from placebo. Two secondary memory scores did improve. The trial was funded by the ingredient's manufacturer, which employed three of the five authors.
Alpha-GPC's acute trial gave 20 resistance-trained men 315mg or 630mg once. Stroop scores improved; the Flanker and N-Back tests did not. Separately, a South Korean cohort of over 12 million adults linked prescribed alpha-GPC use with higher 10-year stroke risk (adjusted HR 1.46). That is an association, not proof of cause.
A 2015 review concluded tyrosine helps cognition mainly in short, stressful or demanding situations. Doses are large: one trial used a single 2g dose, another 150mg per kg of body weight.
A systematic review of rhodiola found three of five mental-fatigue trials positive. Every included study had a high or unclear risk of bias, and the authors called the evidence contradictory.
For lion's mane, a 30-person trial in older Japanese adults with mild cognitive impairment used 3g a day for 16 weeks. Scores rose versus placebo, then fell after people stopped. In 18 healthy young adults, a single 3g extract dose did not improve overall cognition or mood.
Huperzine A is a cholinesterase inhibitor. In an NIH-funded phase II trial, 210 people with mild to moderate Alzheimer's disease took placebo or huperzine A. The primary analysis, 200μg twice daily, showed no cognitive benefit at 16 weeks. The authors classed it as Class III evidence of no demonstrable cognitive effect. A secondary 400μg arm improved at 11 weeks, but not significantly by week 16 (p=0.07). See our huperzine A review.
In a six-month trial of 78 Japanese adults with memory complaints, test scores rose similarly in every group, including placebo. Only a low-scoring subgroup improved against its own baseline. That is a within-group change, not a win over placebo.
Proprietary blends. US rules require a blend to list its total weight and its ingredients in descending order by weight. Individual amounts are optional. A blend's total is therefore the ceiling for every ingredient in it.
Underdosing. Check each disclosed dose against the trial dose. A 300mg bacopa trial cannot be matched by a 150mg serving. Our label-reading guide walks through the arithmetic.
"Clinically tested" claims. US advertising guidance says health claims generally need randomised controlled human trials. It also warns that ingredient research may not support claims for a finished product. Dose and formulation should be compared too. "Clinically tested ingredient" implies more than it delivers.
Hidden caffeine amounts. The FDA notes that supplements containing caffeine "voluntarily provide" caffeine content. If the number is missing, you cannot add it to your daily total.
Cognitive Support ($29.90 for 30 capsules) has 10 actives. Two are individually dosed: niacin 8mg NE and vitamin B6 5mg. The other eight sit in a 255mg proprietary blend: GABA, L-tyrosine, caffeine, bacopa, phosphatidylserine, alpha-GPC, L-theanine and huperzine A.
Here is what that means:
If disclosed doses matter most to you, single-ingredient products at stated amounts let you check every number. Our Mind Lab Pro comparison shows a fully disclosed label beating ours on that test.
US orders ship free, and your first order is covered by a 90-day money-back guarantee, one refund per customer. Talk to your doctor or pharmacist first if you take prescription medication, have a heart condition, or are pregnant or breastfeeding.
Some ingredients produce small, specific effects in trials, such as faster attention-switching or better memory scores in older adults. None has shown large, general improvements in healthy people. The dose and the population tested matter as much as the ingredient.
Caffeine has the most consistent acute evidence for alertness. Creatine and bacopa have reasonable trial support for narrower outcomes. "Best" depends on what you want to change and whether the product matches the trial dose.
Not always, but it stops you checking doses. A blend's total weight caps every ingredient inside it. If that total is below a single ingredient's trial dose, that ingredient cannot be at the studied amount.
Some ingredients, such as caffeine, can add to the effects of stimulant medication. Ask your prescriber or pharmacist before combining anything with prescribed medication.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This article is general information, not medical advice. Talk to your doctor or pharmacist before starting a supplement.
Last updated: November 2026